document type sequence filename description text html head title title head body bgcolor white style margin margin bottom font size font family time roman align right exhibit style margin margin bottom font size font family time roman align center confidential treatment requested style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center amendment sublicense agreement style margin margin bottom text indent font size font family time roman this consent amendment agreement this amendment agreement made june nbsp among titan pharmaceutical corporation having principal office oyster point blvd suite south francisco titan novartis pharma corporation having principal office lichtstrasse basel switzerland novartis style margin margin bottom font size font family time roman align center witnesseth style margin margin bottom text indent font size font family time roman whereas aventis formerly hoechst marion rousel hmri titan party that certain license agreement effective december nbsp license agreement style margin margin bottom text indent font size font family time roman whereas titan novartis party that certain sublicense agreement effective november nbsp amended sublicense agreement style margin margin bottom text indent font size font family time roman whereas novartis desire sublicense right obligation under sublicense agreement vanda pharmaceutical corporation organized under delaware vanda pursuant sublicense agreement vanda sublicense agreement party hereto desire facilitate execution venda sublicense agreement pleading certain tennis sublicense agreement term otherwise defined this amendment agreement shall have meaning forth sublicense agreement style margin margin bottom text indent font size font family time roman therefore consideration mutual covenant agreement hereinafter forth other good valuable consideration receipt which hereby acknowledged party hereby agree follows style margin margin bottom text indent font size font family time roman definition definition field forth section nbsp sublicense agreement hereby deleted entirety replaced with following style margin margin bottom margin left text indent font size font family time roman field shall mean treatment human psychiatric disorder including psychotic disorder analgesia provided however that purpose solely vanda sublicense agreement warty approved sublicense thereunder field shall mean application condition disorder case human style margin margin bottom text indent font size font family time roman purpose vanda sublicense agreement approved sublicense thereunder section nbsp sublicense agreement shall deleted entirety style margin margin bottom text indent font size font family time roman purpose vanda sublicense agreement approved sublicense thereunder section nbsp sublicense agreement shalt deleted entirety style margin margin bottom text indent font size font family time roman grant section nbsp sublicense agreement modified provide that each aventis titan novartis will have after notification thereof accordance with sublicense agreement inform vanda objection trademark selection style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential treatment requested style margin margin bottom font size nbsp style margin margin bottom text indent font size font family time roman subsection sublicense agreement shall deleted entirety replaced following style margin margin bottom margin left text indent font size font family time roman nbsp order spread royalty payment hereunder over sufficient period time each those country territory where patent claiming priority date nbsp december nbsp particular country which patent been granted validly claiming iloperidone manufacture formulation hereof field have expired novartis obligation royalty patent such country shell cease novartis sublicensees shall directly hmri royalty percent novartis affiliate sublicensees annual sale product each such country after expiration final remaining patent each such country after such further royalty arising from sale product such country shall hmri novartis affiliate sublicensees shall entitled continue fully paid irrevocable basis accordance with section nbsp style margin margin bottom text indent font size font family time roman subsection sublicense agreement shall entirety replaced following style margin margin bottom margin left font size font family time roman event third part generic version iloperidene actively marketed process patent country that country which only protection relation process manufacture iloperidene been obtained protection iloperidene chemical entity territory where patent been granted validly claiming iloperidene manufacture formulation thereof field exists then subject section nbsp below royalty rate that novartis shall titan novartis affilliate sublicensee annual sale product that process patent country shall percent until such patent expires provided style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign unless otherwise agreed party table style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign small ertain small small information small small small small been small small omitted small small small small filed small small separately small small with small small small small ommission small small onfidential small small treatment small small small small been small small requested small small with small small respect small small small small small small omitted small small portion small table style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential treatment requested style margin margin bottom font size nbsp style margin margin bottom margin left font size font family time roman style margin margin bottom text indent font size font family time roman purpose venda sublicense agreement approved sublicense thereunder subsection sublicense agreement shall deleted entirety style margin margin bottom text indent font size font family time roman exchange information confidentiality first sentence section nbsp sublicense agreement amended deleting word style margin margin bottom text indent font size font family time roman intellectual property sublicense agreement hereby amended include following provision style margin margin bottom text indent font size font family time roman notwithstanding anything contrary this agreement event that venda sublicense agreement expires terminates entirety with respect country except result material breach that agreement novartis then style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign novartis shall make certain take action necessary that venda delivers invention discovery improvement which arise from venda affiliate sublicensees work relating development manufacture compound product venda than aventis termination expiration venda sublicense agreement table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign novartis will make certain that titan aventis full access titan aventis request venda possession novartis case table style margin margin bottom margin left font size font family time roman venda sublicense agreement expires terminates with respect particular country then requirement forth section above titan aventis right venda shall limited such country style margin margin bottom margin left font size font family time roman titan shall grant license venda novartis forth section nbsp sublicense agreement style margin margin bottom text indent font size font family time roman purpose venda sublicense agreement approved sublicense thereunder subsection sublicense agreement shall deleted entirety replaced with following style margin margin bottom margin left text indent font size font family time roman except other wise expressly provided this sublicense agreement under circumstance shall party hereto result this sublicense agreement obtain ownership interest other right technology know patent pending patent application product biological material other party hmri including item owned controlled discovered invented developed other party hmri transferred other party hmri said party time pursuant this sublicense agreement which direct result study know experimentation compound product style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign small ertain small small information small small small small been small small omitted small small small small filed small small separately small small with small small small small ommission small small onfidential small small treatment small small small small been small small requested small small with small small respect small small small small small small omitted small small portion small table style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential treatment requested style margin margin bottom font size nbsp style margin margin bottom text indent font size font family time roman last paragraph section nbsp sublicense agreement shall deleted their entirety replaced with following style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width style font family time roman font size valign style margin left text indent font size font family time roman with nbsp copy nbsp valign bottom valign bottom titan pharmaceutical style font family time roman font size valign valign bottom valign bottom style font family time roman font size valign valign bottom valign bottom attention style font family time roman font size valign valign bottom valign bottom telephone style font family time roman font size valign valign bottom valign bottom facsimile style font size height height colspan style font family time roman font size valign valign bottom valign bottom style font size height height colspan style font family time roman font size valign valign bottom valign bottom style font family time roman font size valign valign bottom valign bottom telephone style font family time roman font size valign valign bottom valign bottom facsimile table style margin margin bottom text indent font size font family time roman effectiveness this amendment agreement shall deemed effective date hereof style margin margin bottom text indent font size font family time roman miscellaneous style margin margin bottom text indent font size font family time roman agreement amended subject provision this section nbsp this amendment agreement shall deemed amendment sublicense agreement reference agreement other document instrument agreement writing hereafter shall deemed refer agreement amended hereby style margin margin bottom text indent font size font family time roman representation titan represents date this amendment agreement that titan received prior written consent required section nbsp sublicense agreement have legal power right authority enter into this amendment agreement style margin margin bottom text indent font size font family time roman successor assigns this amendment agreement shall binding upon inure benefit titan novartis their respective successor assigns style margin margin bottom text indent font size font family time roman governing this amendment agreement shall deemed tore been made state york form execution validity construction effect shall determined accordance with state york without regard york other jurisdiction conflict principle style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign small ertain small small information small small small small been small small omitted small small small small filed small small separately small small with small small small small ommission small small onfidential small small treatment small small small small been small small requested small small with small small respect small small small small small small omitted small small portion small table style page break before always size style color width align center style margin margin bottom font size font family time roman align center confidential treatment requested style margin margin bottom font size nbsp style margin margin bottom text indent font size font family time roman witness whereof panic hereby have executed this agreement proper person thereunto duly authorized style font size margin margin bottom nbsp align right table cellspacing cellpadding width border style border collapse collapse font family time roman font size width valign bottom width width style font family time roman font size valign bottom colspan nowrap font style font size titan pharmaceutical font style font size height height colspan style font family time roman font size valign valign bottom nbsp valign bottom style margin margin bottom border bottom solid font size font family time roman sunil bmonsel style font family time roman font size valign name valign bottom nbsp valign bottom sunil bmonsel style font family time roman font size valign title valign bottom nbsp valign bottom exec vice president style font size height colspan style font family time roman font size valign colspan novartis pharma style font size height height colspan style font family time roman font size valign valign bottom nbsp valign bottom style margin margin bottom border bottom solid font size font family time roman signatory unknown style font size height height colspan style font family time roman font size valign name valign bottom nbsp valign bottom style line height margin margin bottom border bottom solid nbsp style font size height height colspan style font family time roman font size valign title valign bottom nbsp valign bottom style line height margin margin bottom border bottom solid nbsp style font size height height colspan style font family time roman font size valign valign bottom nbsp valign bottom style margin margin bottom border bottom solid font size font family time roman hevre girsault style font family time roman font size valign name valign bottom nbsp valign bottom hevre girsault style font family time roman font size valign title valign bottom nbsp valign bottom head nbsp global nbsp partnering nbsp business nbsp development nbsp nbsp licencsing style font size height height colspan style font family time roman font size valign valign bottom nbsp valign bottom style margin margin bottom border bottom solid font size font family time roman chakraborti style font family time roman font size valign name valign bottom nbsp valign bottom chakraborti style font family time roman font size valign title valign bottom nbsp valign bottom senior legal counsel table body html text document